News
Significant progress is being made toward diagnosis, evaluation and management of sensori-motor dysfunction, gut microbiota, gut-brain axis, nutrition, eosinophilic esophagitis. Read the most recent news here.
Gut Microbiota for Health World Summit 2024
How will gut microbiome remedies transform your practice to improve GI patient care? Discover next-gen therapies and probiotics at GMFH2024, March 23-24, in Washington. Don't miss out on the opportunity to engage with the forefront of gut microbiome research. We are looking forward to meeting you in Washington!
The Nine Item Avoidant restrictive food intake disorder Screen (NIAS) is now available in French (NIAS-FR)
Clinical experts in neurogastroenterology from four medical centres in France and Belgium collaborated to translate the Nine Item Avoidant Restrictive Food Intake Disorder Screen (NIAS), originally available in English, into French (NIAS-FR).
Call for the next President of the European Society of Neurogastroenterology and Motility
The Steering Committee herewith would like to invite you to nominate a suitable colleague or personally apply for the position of ESNM President for a four-year term starting Fall 2024 with possibility of re-election. The Steering Committee will propose the candidate to the General Assembly for final ratification.
Successful SAGIM conference
The conference of the Scandinavian Society for Motility and Neurogastroenterology (SAGIM) was successfully held for the 11th time in Copenhagen. 56 participants, mainly from all over Europe, but also a few from outside Europe, attended the conference. Seven PhD students participated in the PhD network meeting and presented their posters at the SAGIM meeting.
Special symposium at DGNM annual meeting
In addition to numerous specialist lectures and discussions, this year's DGNM Annual Meeting will offer a special highlight: an international symposium with renowned speakers and comprehensive lectures on neurogastroenterology. DGNM looks forward to cutting-edge contributions from speakers from Belgium, the United Kingdom and the USA, and registration is still open.
Abstract: AI Chatbot and Managing Gastroesophageal Reflux Disease (GERD)
Artificial Intelligence (AI) is reshaping healthcare by accelerating diagnostics, personalizing treatments, and improving decision-making. From advanced imaging to drug discovery, AI's potential is driving innovations that promise more efficient healthcare and better patient outcomes.
New Webinarseries "1st International School of Gut Microbiota in Digestive Disease"
Registration is still open for our "1st International School of Gut Microbiota in Digestive Disease". Participants will have the opportunity to interact with key opinion leaders that will serve as faculty in this unique event. We are looking forward to meeting you!
IBSdays postponed
The IBS Days 2024 in Bologna (originally from April 22nd - 24th) are postponed to June 17th - 19th! Under the slogan “New Insights for a better Management of Irritable Bowel Syndrome” the conference will take place at the Palazzo Re Enzo in Bologna, Italy and will focus on the latest findings and treatments for IBS. For now, you can find more information on our website and in the future on the official IBS Days 2024 website.